vs

Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and Tonix Pharmaceuticals Holding Corp. (TNXP). Click either name above to swap in a different company.

CHICAGO RIVET & MACHINE CO is the larger business by last-quarter revenue ($6.0M vs $5.4M, roughly 1.1× Tonix Pharmaceuticals Holding Corp.). CHICAGO RIVET & MACHINE CO runs the higher net margin — -19.3% vs -870.3%, a 851.0% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs 45.9%). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-41.5M). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs -12.7%).

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

CVR vs TNXP — Head-to-Head

Bigger by revenue
CVR
CVR
1.1× larger
CVR
$6.0M
$5.4M
TNXP
Growing faster (revenue YoY)
TNXP
TNXP
+62.9% gap
TNXP
108.8%
45.9%
CVR
Higher net margin
CVR
CVR
851.0% more per $
CVR
-19.3%
-870.3%
TNXP
More free cash flow
CVR
CVR
$41.5M more FCF
CVR
$24.3K
$-41.5M
TNXP
Faster 2-yr revenue CAGR
TNXP
TNXP
Annualised
TNXP
47.4%
-12.7%
CVR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVR
CVR
TNXP
TNXP
Revenue
$6.0M
$5.4M
Net Profit
$-1.2M
$-46.9M
Gross Margin
2.7%
80.4%
Operating Margin
-15.3%
-895.8%
Net Margin
-19.3%
-870.3%
Revenue YoY
45.9%
108.8%
Net Profit YoY
68.0%
-112.2%
EPS (diluted)
$-4.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVR
CVR
TNXP
TNXP
Q4 25
$6.0M
$5.4M
Q3 25
$7.4M
$3.3M
Q2 25
$7.3M
$2.0M
Q1 25
$7.2M
$2.4M
Q4 24
$4.1M
$2.6M
Q3 24
$7.0M
$2.8M
Q2 24
$8.1M
$2.2M
Q1 24
$7.9M
$2.5M
Net Profit
CVR
CVR
TNXP
TNXP
Q4 25
$-1.2M
$-46.9M
Q3 25
$67.6K
$-32.0M
Q2 25
$-395.0K
$-28.3M
Q1 25
$401.0K
$-16.8M
Q4 24
$-3.6M
$-22.1M
Q3 24
$-1.4M
$-14.2M
Q2 24
$142.1K
$-78.8M
Q1 24
$-698.0K
$-14.9M
Gross Margin
CVR
CVR
TNXP
TNXP
Q4 25
2.7%
80.4%
Q3 25
18.1%
58.4%
Q2 25
13.4%
-63.8%
Q1 25
22.9%
61.2%
Q4 24
-43.7%
54.2%
Q3 24
10.0%
44.9%
Q2 24
17.6%
-52.5%
Q1 24
9.5%
33.1%
Operating Margin
CVR
CVR
TNXP
TNXP
Q4 25
-15.3%
-895.8%
Q3 25
0.9%
-1005.1%
Q2 25
-5.7%
-1416.2%
Q1 25
1.0%
-660.9%
Q4 24
-86.4%
-870.6%
Q3 24
-11.8%
-551.2%
Q2 24
1.3%
-3501.6%
Q1 24
-11.5%
-860.2%
Net Margin
CVR
CVR
TNXP
TNXP
Q4 25
-19.3%
-870.3%
Q3 25
0.9%
-972.9%
Q2 25
-5.4%
-1415.0%
Q1 25
5.5%
-692.8%
Q4 24
-88.0%
-856.2%
Q3 24
-20.8%
-503.6%
Q2 24
1.8%
-3567.8%
Q1 24
-8.9%
-601.9%
EPS (diluted)
CVR
CVR
TNXP
TNXP
Q4 25
$-4.28
Q3 25
$-3.59
Q2 25
$-3.86
Q1 25
$-2.84
Q4 24
$2302.65
Q3 24
$-22.68
Q2 24
$-1920.85
Q1 24
$-535.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVR
CVR
TNXP
TNXP
Cash + ST InvestmentsLiquidity on hand
$1.7M
$207.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$18.8M
$245.2M
Total Assets
$23.3M
$277.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVR
CVR
TNXP
TNXP
Q4 25
$1.7M
$207.6M
Q3 25
$1.7M
$190.1M
Q2 25
$1.2M
$125.3M
Q1 25
$765.6K
$131.7M
Q4 24
$2.2M
$98.8M
Q3 24
$2.2M
$28.2M
Q2 24
$2.6M
$4.2M
Q1 24
$2.7M
$7.0M
Total Debt
CVR
CVR
TNXP
TNXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
$8.7M
Q3 24
$9.4M
Q2 24
$10.1M
Q1 24
$10.8M
Stockholders' Equity
CVR
CVR
TNXP
TNXP
Q4 25
$18.8M
$245.2M
Q3 25
$20.0M
$231.1M
Q2 25
$20.0M
$168.0M
Q1 25
$20.4M
$180.4M
Q4 24
$20.0M
$139.6M
Q3 24
$23.7M
$74.2M
Q2 24
$25.2M
$42.1M
Q1 24
$25.2M
$108.1M
Total Assets
CVR
CVR
TNXP
TNXP
Q4 25
$23.3M
$277.2M
Q3 25
$24.0M
$252.4M
Q2 25
$23.6M
$187.4M
Q1 25
$24.1M
$192.9M
Q4 24
$23.4M
$162.9M
Q3 24
$26.4M
$95.0M
Q2 24
$27.3M
$70.3M
Q1 24
$27.8M
$135.3M
Debt / Equity
CVR
CVR
TNXP
TNXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
0.06×
Q3 24
0.13×
Q2 24
0.24×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVR
CVR
TNXP
TNXP
Operating Cash FlowLast quarter
$116.4K
$-39.6M
Free Cash FlowOCF − Capex
$24.3K
$-41.5M
FCF MarginFCF / Revenue
0.4%
-770.4%
Capex IntensityCapex / Revenue
1.5%
34.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.6M
$-103.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVR
CVR
TNXP
TNXP
Q4 25
$116.4K
$-39.6M
Q3 25
$638.0K
$-28.8M
Q2 25
$28.2K
$-14.8M
Q1 25
$-2.0M
$-16.6M
Q4 24
$-60.1K
$-14.6M
Q3 24
$-58.2K
$-18.8M
Q2 24
$363.5K
$-9.9M
Q1 24
$-398.8K
$-17.6M
Free Cash Flow
CVR
CVR
TNXP
TNXP
Q4 25
$24.3K
$-41.5M
Q3 25
$492.1K
$-29.7M
Q2 25
$-22.8K
$-15.4M
Q1 25
$-2.1M
$-16.6M
Q4 24
$-118.1K
$-14.6M
Q3 24
$-368.9K
$-18.8M
Q2 24
$58.0K
Q1 24
$-491.8K
$-17.7M
FCF Margin
CVR
CVR
TNXP
TNXP
Q4 25
0.4%
-770.4%
Q3 25
6.7%
-904.1%
Q2 25
-0.3%
-768.8%
Q1 25
-28.3%
-682.8%
Q4 24
-2.9%
-566.7%
Q3 24
-5.3%
-666.5%
Q2 24
0.7%
Q1 24
-6.3%
-712.4%
Capex Intensity
CVR
CVR
TNXP
TNXP
Q4 25
1.5%
34.8%
Q3 25
2.0%
29.2%
Q2 25
0.7%
26.4%
Q1 25
0.6%
0.2%
Q4 24
1.4%
0.1%
Q3 24
4.5%
0.3%
Q2 24
3.8%
0.0%
Q1 24
1.2%
4.4%
Cash Conversion
CVR
CVR
TNXP
TNXP
Q4 25
Q3 25
9.44×
Q2 25
Q1 25
-5.01×
Q4 24
Q3 24
Q2 24
2.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

TNXP
TNXP

Zembrace Symtouch$3.1M58%
Other$2.3M42%

Related Comparisons